Abstract
Carcinoid tumors of the lung are primary pulmonary neoplasms which typically occur in middle-aged individuals. The most common presentations are persistent cough, possibly with hemoptysis, or recurrent episodes of pneumonia. Pulmonary carcinoid tumors occur as either low-grade typical carcinoid (TC) or more aggressive intermediate-grade atypical carcinoid (AC). Histologically, both are characterized by nests of neuroendocrine cells arising from neuroendocrine cells of the airway epithelium. The atypical form is defined by the presence of either punctate necrosis or a mitotic rate from 2 to 10 mitotic figures/2 mm2; they are associated with more aggressive behavior and lower overall rates of survival when compared to TC.
Diffuse idiopathic neuroendocrine cell hyperplasia (DIPNECH) and carcinoid tumorlets are two forms of neuroendocrine cell hyperplasia that affect predominantly women in their 50s and 60s. Both entities will present with multiple pulmonary nodules. In DIPNECH, multiple small nodules are seen bilaterally, commonly showing a linear pattern along bronchi and bronchioles on radiographic imaging, whereas tumorlets are small (≤5 mm) localized lesions associated with underlying primary lung disease.
All these entities demonstrate similar immunohistochemical profiles, with positivity for neuroendocrine markers and variable expression of TTF-1. As such, their differentiation is based largely on their morphologic features in conjunction with both clinical and radiographic correlation. This is particularly true in making the diagnosis of DIPNECH.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Linnoila RI. Functional facets of the pulmonary neuroendocrine system. Lab Investig. 2006;86(5):425–44.
Rekhtman N. Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med. 2010;134(11):1628–38.
Mengoli MC, Rossi G, Cavazza A, Franco R, Marino FZ, Migaldi M, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) syndrome and carcinoid tumors with/without NECH: a clinicopathologic, radiologic, and Immunomolecular comparison study. Am J Surg Pathol. 2018;42(5):646–55.
Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015;10(9):1243–60.
Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist. 2008;13(12):1255–69.
Koo CW, Baliff JP, Torigian DA, Litzky LA, Gefter WB, Akers SR. Spectrum of pulmonary neuroendocrine cell proliferation: diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, tumorlet, and carcinoids. AJR Am J Roentgenol. 2010;195(3):661–8.
Dincer HE, Podgaetz E, Andrade RS. Pulmonary neuroendocrine tumors: Part I. Spectrum and characteristics of tumors. J Bronchology Interv Pulmonol. 2015;22:267–73.
Sheppard MN. Nuclear pleomorphism in typical carcinoid tumours of the lung: problems in frozen section interpretation. Histopathology. 1997;30(5):478–80.
Marchevsky AM, Hendifar A, Walts AE. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence. Mod Pathol. 2018;31(10):1523–31.
Pelosi G, Rindi G, Travis WD, Papotti M. Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice. J Thorac Oncol. 2014;9(3):273–84.
García-Yuste M, Matilla JM. The significance of histology: typical and atypical bronchial carcinoids. Thorac Surg Clin. 2014;24(3):293–7.
Rossi G, Cavazza A, Spagnolo P, Sverzellati N, Longo L, Jukna A, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome. Eur Respir J. 2016;47(6):1829–41.
Davies SJ, Gosney JR, Hansell DM, Wells AU, du Bois RM, Burke MM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax. 2007;62(3):248–52.
Gorshtein A, Gross DJ, Barak D, Strenov Y, Refaeli Y, Shimon I, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors. Cancer. 2012;118(3):612–9.
Marchevsky AM, Wirtschafter E, Walts AE. The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH? Human Patholol. 2015;46(2):176–81.
Ginsberg MS, Akin O, Berger DM, Zakowski MF, Panicek DM. Pulmonary Tumorlets: CT findings. Am J Roentgenol. 2004;183(2):293–6.
Kallianos A, Velentza L, Zarogoulidis P, Baka S, Kosmidis C, Labaki S, et al. Progressive dyspnea due to pulmonary carcinoid tumorlets. Respir Med Case Rep. 2017;6(21):84–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Morse, R.J., Xu, H. (2022). Typical Versus Atypical Carcinoid and Diffuse Idiopathic Neuroendocrine Cell Hyperplasia Versus Carcinoid Tumorlets. In: Xu, H., Ricciotti, R.W., Mantilla, J.G. (eds) Practical Lung Pathology. Practical Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-031-14402-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-031-14402-8_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14401-1
Online ISBN: 978-3-031-14402-8
eBook Packages: MedicineMedicine (R0)